Patent Assignment
Reel/Frame 073302/0334
Security Interest
Recorded: 2025-12-23
Pages: 11
Assignors
COLLEGIUM PHARMACEUTICAL, INC.
Executed: 2025-12-23
BIODELIVERY SCIENCES INTERNATIONAL, INC.
Executed: 2025-12-23
IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Executed: 2025-12-23
Assignee
TRUIST BANK, A NORTH CAROLINA CHARTERED BANK
303 PEACHTREE STREET NE, ATLANTA, GEORGIA, 30308
Covered Properties
(39)
Abuse resistant transmucosal drug delivery device
Transmucosal Delivery Devices with Enhanced Uptake
Methods and Compositions for Treatment of Attention Deficit Disorder
Abuse-Resistant Mucoadhesive Devices for Delivery of Buprenorphine
Transmucosal Drug Delivery Devices for Use in Chronic Pain Relief
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Method of Treatment of Attention Deficit Hyperactivity Disorder
Methods of Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Transmucosal Delivery Devices with Enhanced Uptake
Transmucosal Delivery Devices with Enhanced Uptake
Process of Making Stable Abuse-Deterrent Oral Formulations
Patent:
9,737,530 →
Application:
15/255,859 →
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methods of Treatment of Attention Deficit Hyperactivity Disorder
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Process of Making Stable Abuse-Deterrent Oral Formulations
Process of Making Stable Abuse-Deterrent Oral Formulations
Process of Making Stable Abuse-Deterrent Oral Formulations
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Tamper-Resistant Pharmaceutical Compositions of Opioids and Other Drugs
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Application:
17/316,252 →
Publication:
US 2021/0267957
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Application:
18/057,819 →
Publication:
US 2023/0120738
Abuse-Resistant Mucoadhesive Devices for Delivery of Buprenorphine
Application:
18/330,238 →
Publication:
US 2024/0165102
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Abuse-Resistant Mucoadhesive Devices for Delivery of Buprenorphine
Application:
18/788,070 →
Publication:
US 2025/0064796
Process of Making Stable Abuse-Deterrent Oral Formulations
Application:
19/087,090 →
Publication:
US 2025/0213554
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 29, 2012
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 029424/0359 →
Assignment of Assignor's Interest
Nov 29, 2012
From: FINN, ANDREW; VASISHT, NIRAJ
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 029375/0695 →
Corrective Assignment to Correct the Application Number Previously Recorded on Reel 029375 Frame 0695. Assignor(S) Hereby Confirms the Assignment.
Nov 30, 2012
From: FINN, ANDREW; VASISHT, NIRAJ
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 029388/0845 →
Assignment of Assignor's Interest
Jan 2, 2013
From: FINN, ANDREW; VASISHT, NIRAJ
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 029553/0429 →
Security Agreement
Jul 8, 2013
From: BIODELIVERY SCIENCES INTERNATIONAL, INC.; ARIUS TWO, INC.
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 030763/0336 →
Master Development Agreement
Oct 31, 2013
From: HIGHLAND THERAPEUTICS, INC.
To: PHARMAFORM
Reel/Frame 031609/0883 →
Assignment of Assignor's Interest
Oct 31, 2013
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 031552/0812 →
Assignment of Assignor's Interest
Nov 15, 2013
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 031733/0639 →
Corrective Assignment to Correct Assignee/Assignor Names; Previously Recorded at Reel 031609 Frame 0883. Assignor(S) Hereby Confirms the Assignment.
Feb 19, 2014
From: FORMULATION TECHNOLOGIES L.L.C. D/B/A PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032425/0435 →
Assignment of Assignor's Interest
Apr 3, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032611/0146 →
Assignment of Assignor's Interest
Apr 3, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0128 →
Assignment of Assignor's Interest
Apr 3, 2014
From: FORMULATION TECHNOLOGIES, L.L.C. D/B/A PHARR
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032611/0130 →
Assignment of Assignor's Interest
Apr 3, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0124 →
Assignment of Assignor's Interest
Apr 3, 2014
From: FORMULATION TECHNOLOGIES, L.L.C. D/B/A PHARR
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032611/0137 →
Assignment of Assignor's Interest
Apr 3, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032611/0144 →
Assignment of Assignor's Interest
Apr 3, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0122 →
Assignment of Assignor's Interest
Apr 3, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0126 →
Assignment of Assignor's Interest
Apr 25, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032799/0931 →
Assignment of Assignor's Interest
Apr 25, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032799/0978 →
Assignment of Assignor's Interest
Apr 25, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032800/0028 →
Master Development Agreement
May 8, 2014
From: FORMULATION TECHNOLOGIES L.L.C. D/B/A PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032845/0794 →
Assignment of Assignor's Interest
Jan 7, 2015
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034741/0294 →
Assignment of Assignor's Interest
Jan 7, 2015
From: FORMULATION TECHNOLOGIES LLC DBA PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 034729/0571 →
Assignment of Assignor's Interest
Jan 7, 2015
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034654/0547 →
Assignment of Assignor's Interest
Jan 7, 2015
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034652/0787 →